Related references
Note: Only part of the references are listed.Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens
Emanuele Nicastri et al.
CURRENT HIV RESEARCH (2008)
Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial
Corey Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+CD8+ T cell activation levels in primary HIV-1 infection
Lishomwa C. Ndhlovu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy
Andrew Lim et al.
AIDS (2007)
Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis
Luciano Potena et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
Priscilla Y. Hsue et al.
AIDS (2006)
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy
Craig S. Miller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
CD4+T cell receptor repertoire perturbations in HIV-1 infection: Association with plasma viremia and disease progression
U Mathotra et al.
CLINICAL IMMUNOLOGY (2006)
HIV disease: fallout from a mucosal catastrophe?
JM Brenchley et al.
NATURE IMMUNOLOGY (2006)
Depletion of regulatory T cells in HIV infection is associated with immune activation
MP Eggena et al.
JOURNAL OF IMMUNOLOGY (2005)
Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability
C Hilscher et al.
NUCLEIC ACIDS RESEARCH (2005)
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection
L Papagno et al.
PLOS BIOLOGY (2004)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons
J Jebbink et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function
MA Jacobson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Lack of Epstein-Barr virus-and HIV specific CD27-CD8+T cells is associated with progression to viral disease in HIV infection
D van Baarle et al.
AIDS (2002)
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
RR Razonable et al.
TRANSPLANTATION (2002)
Share Paper
